Nombre de los medicamentos: Genérico y Comercial – Aprenda acerca de las causas, los síntomas, el diagnóstico y el tratamiento de los Manuales MSD. Se ha demostrado que los antibióticos aplicados en el párpado alivian los síntomas y resuelven la infección bacteriana de los párpados. Contraindicadas en casos de hipersensibilidad a cualquiera de los antibióticos del grupo de la neomicina (aminoglucósidos), ya que existe sensibilización.
|Published (Last):||5 August 2009|
|PDF File Size:||5.66 Mb|
|ePub File Size:||7.8 Mb|
|Price:||Free* [*Free Regsitration Required]|
oftalmiicos Subjects of any age at Visit 1 Note: Both Female Only Male Only. The majority of patients positively responded to treatment. Age, sex, causes of eye loss, affected eye, conjunctival disease, type of cavity, length of time of prosthesis use, microbiological result, hygienic handling and response to treatment were the analyzed variables.
The trial involves single site in the Member State concerned. The primary objective of this study is to evaluate the efficacy of SHP based on clinical resolution defined as absence of bulbar conjunctival injection and ocular conjunctival discharge compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5.
Gotas para los ojos: ¿cuáles son más adecuadas para usted?
Have a preplanned overnight hospitalization during the period of the study. Have a history of recurrent corneal erosion syndrome, either idiopathic or secondary to previous corneal trauma or dry eye syndrome; presence of corneal epithelial defect or any significant corneal opacity at Visit 1.
Full list of Exclusion criteria can be found in the protocol. Plans for treatment or care after the offtalmicos has ended the participation in the trial if it is different from the expected normal treatment of that condition. How to search [pdf]. Tener un herpes ocular activo o antecedente. Clinical trials The European Union Clinical Trials Register allows offalmicos to search for protocol and results information on: Allergic conjunctivitis and conjunctival retraction are the most frequent illnesses in the patients wearing ocular prosthesis for more than one year, due to Staphylococcus aureus presence resulting from frequent hygienic handling of the prosthesis.
Conocimiento, capacidad y voluntad para cumplir plenamente con los procedimientos y restricciones del estudio por los progenitores, tutor o representante legal autorizado, si procede. Have active or a history of ocular herpes.
Use of rescue medication Safety Endpoints: Visit 3 Day 5 2. EU Clinical Trials Register. Cancer AND drug name. Le siguen, en orden de frecuencia, las infecciones y el glaucoma. Have any known clinically significant optic nerve defects.
Questionnaire of the psychosocial profile of the patient with anophthalmia with indication of ocular prosthesis.
Clinical resolution status defined as absence of bulbar conjunctival injection and ocular conjunctival discharge in the study eye at Visit 3 Day 5 between SHP and placebo. Key Secondary Efficacy Endpoints: For these items you should use the filters and not add them to your search terms in the text field. Sujetos de cualquier edad en la visita 1 Nota: Uso de medicamentos de rescate.
Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline in the study eye at Visit 3 Day 5 between SHP and placebo. Time to clinical resolution based upon assessments at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 9. Definition of the end ottalmicos the trial and justification abtibioticos it is not the last visit of the last subject undergoing the trial.
Presence of antibioticso, active condition in the posterior segment that requires invasive treatment eg, intravitreal treatment with vascular endothelial growth factor inhibitors or corticosteroids and may progress during the study participation period. Current or relevant history of physical or psychiatric illness, any medical disorder that may make the subject unlikely to fully complete the study, or any condition that presents undue risk from the investigational product or procedures. Quantitaty eye lid evaluation of anophthalmic cavity carriers with external ocular prosthesis.
Have a clinical diagnosis of suspected bacterial conjunctivitis antibioticls at least 1 eye confirmed by the presence of the following minimal clinical signs and symptoms in that same eye: Pneumonia AND sponsor name.
Antibióticos en productos para Ganadería en Engormix
Nicodemo D, Ferreira LM. Tener una enfermedad ocular significativa p. Committee on Advanced therapies CAT has issued a classification for this product. Review by the Competent Authority or Ethics Committee in the country concerned.
Similarly, most of the anophthalmic cavities are atypical in adults with loss of eyeball from traumatism. Neonates or infants ie.
The IMP has been designated in this indication as an orphan drug in the Community. Clinical resolution status of bacterial conjunctivitis at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 3.
The global clinical score defined as the sum of bulbar conjunctival injection and ocular conjunctival discharge and change from baseline in the global clinical score at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 6. Have known or suspected intolerance or hypersensitivity to the investigational product, closely related compounds, or any of the stated ingredients. Trials with results Trials without results.
Absolute and change from baseline of the individual clinical signs bulbar conjunctival injection and ocular conjunctival discharge at Visits 2 Day 33 Day 54 Oftalmics 8and 5 Day 12 in the study eye 5. Bacterial eradication status anhibioticos as absence of all bacterial species present at or above pathological threshold at baseline as assessed by bacterial culture at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 4.
Expanded clinical resolution status, defined as a global clinical score oftalmixos 0, 1, or 2 with neither injection nor discharge having a score of 2, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 8. Presence of any significant ophthalmic condition eg, Retinopathy of Prematurity, congenital cataract, congenital glaucoma or other congenital disorder with ophthalmic involvement that could affect study variables.
Combination product that includes a device, but does not involve an Advanced Therapy. Clinicalfeatures of ocular trauma in emergency departament. Be willing to discontinue contact lens wear for oftwlmicos duration of the study.
Date on which this record was first entered in the EudraCT database:.